Multiple myeloma involving central nervous system: High frequency of chromosome 17p13.1 (p53) deletions

Hong Chang, Stephen Sloan, Dan Li, Alexander Keith Stewart

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Central nervous system (CNS) involvement is an unusual manifestation in multiple myeloma (MM). The molecular basis of CNS myeloma is poorly understood. MM is characterized by translocations involving the immunoglobulin heavy chain (IgH) locus and frequent 13q deletions. Alterations of p53 or c-myc in MM may represent secondary changes associated with disease progression. We investigated nine patients with CNS MM using interphase fluorescence in situ hybridization (FISH) combined with immunofluorescence detection of the cytoplasmic light chain (cIg-FISH) for the presence of above genomic aberrations. Of nine patients studied, eight cases had hemizygous p53 deletion and 4 had 13q deletions. Of the patients with 13q deletions, two had IgH translocations, one involving 4p16.3 (FGFR3), the other involving 16q23 (c-maf). The high incidence of p53 deletions detected by cIg-FISH in CNS myeloma may be a marker for chromosomal instability, and may be associated with metastatic features of myeloma cells.

Original languageEnglish (US)
Pages (from-to)280-284
Number of pages5
JournalBritish Journal of Haematology
Volume127
Issue number3
DOIs
StatePublished - Nov 2004
Externally publishedYes

Fingerprint

Multiple Myeloma
Central Nervous System
Chromosomes
Fluorescence In Situ Hybridization
Immunoglobulin Heavy Chains
Chromosomal Instability
Interphase
Fluorescent Antibody Technique
Disease Progression
Light
Incidence
13q deletion syndrome

Keywords

  • Central nervous system
  • Fluorescence in situ hybridization
  • Myeloma
  • p53 deletions
  • Prognostic factor

ASJC Scopus subject areas

  • Hematology

Cite this

Multiple myeloma involving central nervous system : High frequency of chromosome 17p13.1 (p53) deletions. / Chang, Hong; Sloan, Stephen; Li, Dan; Stewart, Alexander Keith.

In: British Journal of Haematology, Vol. 127, No. 3, 11.2004, p. 280-284.

Research output: Contribution to journalArticle

@article{263358197b2f45cd95fc6ee5e89044fc,
title = "Multiple myeloma involving central nervous system: High frequency of chromosome 17p13.1 (p53) deletions",
abstract = "Central nervous system (CNS) involvement is an unusual manifestation in multiple myeloma (MM). The molecular basis of CNS myeloma is poorly understood. MM is characterized by translocations involving the immunoglobulin heavy chain (IgH) locus and frequent 13q deletions. Alterations of p53 or c-myc in MM may represent secondary changes associated with disease progression. We investigated nine patients with CNS MM using interphase fluorescence in situ hybridization (FISH) combined with immunofluorescence detection of the cytoplasmic light chain (cIg-FISH) for the presence of above genomic aberrations. Of nine patients studied, eight cases had hemizygous p53 deletion and 4 had 13q deletions. Of the patients with 13q deletions, two had IgH translocations, one involving 4p16.3 (FGFR3), the other involving 16q23 (c-maf). The high incidence of p53 deletions detected by cIg-FISH in CNS myeloma may be a marker for chromosomal instability, and may be associated with metastatic features of myeloma cells.",
keywords = "Central nervous system, Fluorescence in situ hybridization, Myeloma, p53 deletions, Prognostic factor",
author = "Hong Chang and Stephen Sloan and Dan Li and Stewart, {Alexander Keith}",
year = "2004",
month = "11",
doi = "10.1111/j.1365-2141.2004.05199.x",
language = "English (US)",
volume = "127",
pages = "280--284",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Multiple myeloma involving central nervous system

T2 - High frequency of chromosome 17p13.1 (p53) deletions

AU - Chang, Hong

AU - Sloan, Stephen

AU - Li, Dan

AU - Stewart, Alexander Keith

PY - 2004/11

Y1 - 2004/11

N2 - Central nervous system (CNS) involvement is an unusual manifestation in multiple myeloma (MM). The molecular basis of CNS myeloma is poorly understood. MM is characterized by translocations involving the immunoglobulin heavy chain (IgH) locus and frequent 13q deletions. Alterations of p53 or c-myc in MM may represent secondary changes associated with disease progression. We investigated nine patients with CNS MM using interphase fluorescence in situ hybridization (FISH) combined with immunofluorescence detection of the cytoplasmic light chain (cIg-FISH) for the presence of above genomic aberrations. Of nine patients studied, eight cases had hemizygous p53 deletion and 4 had 13q deletions. Of the patients with 13q deletions, two had IgH translocations, one involving 4p16.3 (FGFR3), the other involving 16q23 (c-maf). The high incidence of p53 deletions detected by cIg-FISH in CNS myeloma may be a marker for chromosomal instability, and may be associated with metastatic features of myeloma cells.

AB - Central nervous system (CNS) involvement is an unusual manifestation in multiple myeloma (MM). The molecular basis of CNS myeloma is poorly understood. MM is characterized by translocations involving the immunoglobulin heavy chain (IgH) locus and frequent 13q deletions. Alterations of p53 or c-myc in MM may represent secondary changes associated with disease progression. We investigated nine patients with CNS MM using interphase fluorescence in situ hybridization (FISH) combined with immunofluorescence detection of the cytoplasmic light chain (cIg-FISH) for the presence of above genomic aberrations. Of nine patients studied, eight cases had hemizygous p53 deletion and 4 had 13q deletions. Of the patients with 13q deletions, two had IgH translocations, one involving 4p16.3 (FGFR3), the other involving 16q23 (c-maf). The high incidence of p53 deletions detected by cIg-FISH in CNS myeloma may be a marker for chromosomal instability, and may be associated with metastatic features of myeloma cells.

KW - Central nervous system

KW - Fluorescence in situ hybridization

KW - Myeloma

KW - p53 deletions

KW - Prognostic factor

UR - http://www.scopus.com/inward/record.url?scp=7944227334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7944227334&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2004.05199.x

DO - 10.1111/j.1365-2141.2004.05199.x

M3 - Article

C2 - 15491286

AN - SCOPUS:7944227334

VL - 127

SP - 280

EP - 284

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -